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FIG. 1. Appearance of the patient described at 13 years of age prior to any medication.LUIS G. SOBRINHO* Departments of Pediatricsand Obstetrics
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The changes in the endocrine system that occur at the time of puberty are
not completely understood. Development of secondary sexual characteristics
is due chiefly to the secretion of gonadal steroids, but the role of the in-
creased adrenal androgen secretion,," as wellas thepossibility of asignificant
increase in sensitivity to exogenous testosterone at the time of puberty,8 re-
mains obscure.
In an attempt to learn more about the non-gonadal physiological mecha-
nisms involved in normal pubertal development, this paper describes a pa-
tient with the syndrome of testicular feminization who had been castrated
in early childhood but went on to develop breasts at puberty.
CASE REPORT
M.A. (YNHH 67-80-45), a white girl, was born on 5/8/57 weighing 7
pounds, 2 ounces and measuring 19%2 inches. Pregnancy and delivery were
normal.
At 13 months of age, a right inguinal hernia was discovered. During re-
pair at 18 months of age, the hernia sac was found to contain a gonad which
at the time was thought to be an ovary and reinserted into the abdomen.
Three days later the baby developed an acute and painful left inguinal mass.
Biopsy of this mass demonstrated testicular tissue. The incision was ex-
tended and the abdomen opened for pelvic exploration. No uterus or tubes
were found. Only the aforementioned gonads, now defined as testes, were
present. Since there was no enlargement of the clitoris, and the labia, hymen,
and vagina seemed to be normal for an 18-month old girl, the diagnosis of
male pseudohermaphroditism was made and both gonads removed. Patho-
logical examination confirmed that both gonads were normal prepubertal
testes. A buccal smear was chromatin negative.
Subsequently, the child has done well; she was seen for the first time at
the Yale-New Haven Hospital at 11 years of age. A delightful young girl,
she was 5'2" tall and weighed 124 lbs. Her school work was good and her
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behavior was in every way that of a normal girl. She was discharged with-
out medication and asked to return the following year for evaluation as to
possible therapy.
When next seen at 13 years of age the patient had developed adolescent
sized breasts (Fig. 1). The left breast was somewhat larger than the right,
but there was bilateral glandular tissue. The areolae were immature. There
was no axillary or pubic hair but a few vulvar hairs were noted. The labia
were slightly atrophic and prepubertal; the clitoris was normal. The vagina
was one inch deep and poorly epithelialized; no pelvic organs were palpated
on rectal examination. A vaginal smear revealed 15 o cornified cells, 85%o
intermediate cells, and no basal cells. A chromosomal study performed at
this time revealed a 44 XY pattern. The possibility of prior ingestion of any
preparation containing estrogens was carefully discussed and ruled out.
No member of this family has had a comparable condition. The patient
has one brother and two post-pubertal sisters, both of whom have developed
normally and are having menstrual periods. There are no relatives with a
history of infertility and none with anything indicative of sexual ab-
normality.
Because of the rarity of finding breast development in a castrated indi-
TABLE 1. PITUITARY AND ADRENAL RESPONSES To THE ADMINISTRATION OF
EXOGENOUS HORMONES IN A PATIENT WITH FEMINIZING TESTICULAR SYNDROME
17KS 170HCS Estrogens FSH LH
(mg/24 hr.) (mg/24 hr.) (j.g/24 hr.) (,ug/ml.) (,utg/ml.)
Normal basal values 0.10 ± 0.02 ±
for a 13 year old girl 2-6* 4.3 + 1.5** 10-30t 0.02t 0.005t
Basal values for
patient MA 5.9 2.7 120 3.8 .25
ACTH 29 27 49.3 4.3 -
(40 U IV in 8 hours)
Stilbesterol 12 7.8 19.6 1.1 .13
(2 mg PO qd X 4d)
Testosterone Propionate 25 5.4 21.5 1.4 .09
(25 mg IM qd X 4d)
Fluoxymestrone 14 4.5 17.0 2.4 .22
(25 mg PO q 12 hr X 4d)
Dexamethasone 4.1 0.7 15.2 - .32
(2 mg PO qd X 4d)
Dihydrotestosterone
Acetate 12 2.7 24.7 3.3 .33
(25 mg IM qd X 4d)
* Talbot, et al."7 t Kase'
**Wilkins'8 tLee, et al.'0
226
Volume 44, October, 1971Breast growth in castrated patient S
vidual, she was admitted for evaluation. Initial determinations of hemo-
globin, hematocrit, white cell count and differential, blood glucose, BUN,
serum electrolytes and urinalysis were all normal.
Endocrine studies: The urinary excretion of 17 ketosteroids (17KS)
were 5.9 mg/24 hrs. and of hydroxycorticoids (170HCS) (as Porter Silber
chromogens) 2.7 mg/24 hrs. Total estrogens in urine as assayed by a
fluorescence method' were 20 jug/24 hrs. Estradiol in blood was assayed by
a competitive binding system employing uterine cytosol protein as a binder'
and by an immunoassay utilizing anti-estradiol antibodies.6
Both methods for the measurement of estradiol in blood yielded very low
values. No estradiol was detected by use of anti-estradiol antibodies (limit
of sensitivity 10 pcg/ml.) and the immunoassay measured 4 pcg/ml. Follicle
stimulating hormone (FSH) and luteinizing hormone (LH) in blood were
assayed by radioimmunoassay in triplicate.78 FSH in blood was 3.8 jug/ml.
(LER-907) and LH was .25 ,ug/ml. (LER-907). One milligram of LER
907 equals 20 international units of FSH and 48 international units of LH
(Bioassay, second IRP). Normal values in our laboratory for menstruating
women in the follicular phase (mean + S.D.): LH, 0.12 + .04 ,ug/ml. and
FSH, 0.47 -+- 0.13 ,ug/ml. (reference for both-LER 907). The LH values
are not elevated to the same extent as the FSH values.
After discharge, the patient was treated with methyltestosterone 20 mg.
q.d. for six weeks. No increased hair growth, acne, or other androgenic ef-
fects accompanied this treatment. Subsequently, the patient received Stil-
besterol 0.5 mg. q.d. and further breast growth ensued.
DISCUSSION
The observation that exogenous androgen would not masculinize patients
with the syndrome of testicular feminization led Wilkins to suggest that the
basic lesion in this disease was peripheral insensitivity to androgen. Con-
firmatory evidence is that the testes of these patients produced normal
amounts of testosterone both in vivo"'0' and in vitro. Recently it was de-
termined that the skin and other target organs in those patients lacked the
ability to convert testosterone into 5a-dihydrotestosterone, which is pre-
sumed to be one of the active metabolites of the hormone.
The diagnosis of testicular feminization is not easily made before puberty.
Some male pseudohermaphrodites will develop full-blown virilization at
puberty.? In the absence of a family history, the diagnosis was made by
demonstrating over a sufficient period of time clinical unresponsiveness to
methylestosterone.
Despite castration in early childhood, this patient developed breasts. Two
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similar patients who were castrated in childhood and observed throughout
puberty' did not develop breasts, but it is not certain that the male pseudo-
hermaphrodites reported by Giusti' had the syndrome of testicular feminiza-
tion.
The production of endogenous estrogen by this patient was minimal as
judged by her serum values. Metabolite excretion was in the low normal
range but this value was probably misleadingly high. Other phenolic sub-
stances interfere with the assay and its specificity is questionable in the
range of low values.
The serum concentration of estradiol in this patient, though far less than
that found in normal males (around 30 pcg/ml.),' was still enough to in-
duce breast growth in the presence of androgen insensitivity. This phenom-
enon emphasizes the anti-estrogenic effect of androgens in mammary
growth. The large breasts so commonly observed in such patients, when
the diagnosis is made after puberty, (when the testes, as well as the adre-
nals, contribute to the estrogen pool), probably have a similar meaning.
The physiological inhibition of the estrogen effect by androgens is also sug-
gested by the fact that 17 a-methyl-,l-nor testosterone, a nonestrogenic anti-
androgen, has been reported to have induced gynecomastia in 12 out of 13
males.'6
SUMMARY
A patient is evaluated with the syndrome of testicular feminization who
showed breast development at the time of puberty despite castration in early
childhood. The finding of low blood concentration of estradiol (4 pcg/ml.)
is consistent with the contention that mammary tissue develops despite low
estrogen levels because of the unresponsiveness to androgen characteristic
of testicular feminization. That thelarche occurred at a normal age despite
castration in infancy suggests that modifications in steroid production pat-
tern, or peripheral sensitivity, or both, occur at puberty independently of the
presence of gonads.
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